NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Elgi Equipments (ELEQ) Research Report

Summary

We attended Elgi Equipments' analyst meet, where management presented the company's business performance, product innovation, and medium-term strategic roadmap. The ISAAME region is expected to remain the key growth engine, supported by strong traction in the Middle East and a recovery in investment activity following tariff normalization.

Regional Performance

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

  • ISAAME Region: Expected to remain the key growth engine, with strong traction in the Middle East and a recovery in investment activity following tariff normalization.
  • North America: Performance weighed down by structurally lower-margin portable segment and prior tariff impacts; however, underlying initiatives remain intact.
  • Europe: Achieved break-even following cost rationalization, with future growth anchored in market share gains across core markets.
  • Australia: Share gains have partially mitigated broader market weakness.

Revenue and Margin Targets

The company is well-positioned to achieve its USD750mn revenue target with 18% EBITDA margin by FY31, reinforcing a constructive long-term outlook.

Valuation and Recommendation

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

The stock is currently trading at a PE of 36.0x/31.4x on FY27/28E earnings. We roll forward to Mar'28E and maintain our 'Accumulate' rating, valuing the stock at a PE of 35x Mar'28E (35x Sep'27E), arriving at a revised Target Price (TP) of Rs603 (Rs565 earlier).

Investor Takeaway

Investors should consider Elgi Equipments' potential for long-term growth, driven by its strategic roadmap and product innovation.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.